Elliott & Elliott: Biochemistry and Molecular Biology 4e
Please note that some of the sites you will be directed to from this page may require a username and password to access the article.
The role of glycogenin
Van Schaftingen, E., Detheux, M., and Da Cunha, M. V. (1994). Short-term control of glucokinase activity: role of a regulatory protein. FASEB J., 8, 414-19.
Describes the occurrence, properties, and control of this enzyme.
Lipid transport and lipoproteins
Nilsson-Ehle, P., Garfinkel, A. S., and Schotz, M. C. (1980). Lipolytic enzymes and plasma lipoprotein metabolism. Annu. Rev. Biochem., 49, 667-93 [DOI: 10.1146/annurev.bi.49.070180.003315].
General summary of lipoproteins, including useful information at the physiological level.
Angelin, B. and Gibbons, G. (1993). Lipid metabolism. Curr. Opin. Lipidol.. 4, 171-6 [DOI: 10.1097/00041433-199306000-00001].
Overview of lipoproteins
Tall, A. (1995). Plasma lipid transfer proteins. Annu. Rev. Biochem., 64, 235-57 [DOI: 10.1146/annurev.bi.64.070195.001315].
Comprehensive review of cholesterol ester transport protein (CETP), lipid transport, and forward and reverse cholesterol transport between liver and extrahepatic tissues.
Osborne, T. E. (1997). Cholesterol homeostasis: clipping out a slippery regulator. Curr. Biol., 7, R172-4 [DOI: 10.1016/S0960-9822(97)70081-2].
Describes an unusual control of cholesterol synthesis
Gura, T. (1999). Gene linked to faulty cholesterol transport. Science, 285, 814-15 [DOI: 10.1126/science.285.5429.814] [PubMed: 10454927].
A short informative report on the discovery of the way in which cholesterol is removed from cells. The work relates to cholesterol transport out of cells and Tangier disease.
Ballantyne, C. M. (2003). Current and future aims of lipid-lowering therapy: changing paradigms and lessons from the Heart Protection Study on standards of efficacy and safety. Am. J. Cardiol., 92, 3K-9K [DOI: 10.1016/S0002-9149(03)00768-9].
Brewer, H. B. and Santamarina-Fogo, S. (2003). Clinical significance of high-density lipoproteins and the development of atherosclerosis: focus on the role of adenosine triphosphate-binding cassette protein A1 transporter. Am. J. Cardiol., 92, 10K-16K [DOI: 10.1016/S0002-9149(03)00769-0].
Borst, P. and Elferink, R. O. (2002). Mammalian ABC transporters in health and disease. Annu. Rev. Biochem., 71, 537-92 [DOI: 10.1146/annurev.biochem.71.102301.093055].
Rader, D. J. (2003). Regulation of reverse cholesterol transport and clinical implications. Am. J. Cardiol., 92, 42-9 [DOI: 10.1016/S0002-9149(03)00615-5].
Attie, A. D. (2007). ABCA1: at the nexus of cholesterol, HDL and atherosclerosis. Trends Biochem. Sci., 32, 172-9 [DOI: 10.1016/j.tibs.2007.02.001].
Reviews removal of cholesterol from cells and formation of HDL particles.